The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Expert Opinion on Investigational Drugs

• Publication date

  2001-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/13543784.10.10.1819PMID 11772288
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nicotine-induced place preferences following prior nicotine exposure in rats

  2005cited by this paper
• Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in αCGRP-deficient mice

  2001cited by this paper
• A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception.

  2001cited by this paper
• Altered Neuroadaptation in Opiate Dependence and Neurogenic Inflammatory Nociception in αCGRP Deficient Mice

  2001cited by this paper
• Antihyperalgesic activity of epibatidine in the formalin model of facial pain

  2001cited by this paper
• Influence of gender and sex hormones on nicotine acute pharmacological effects in mice.

  2001cited by this paper
• Mecamylamine prevents tolerance but enhances whole brain [3H]epibatidine binding in response to repeated nicotine administration in rats

  2000cited by this paper
• The involvement of spinal Ca(2+)/calmodulin-protein kinase II in nicotine-induced antinociception in mice.

  2000cited by this paper
• Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)‐epibatidine and ABT‐594 in models of persistent inflammatory and neuropathic pain

  2000cited by this paper
• The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain.

  2000influential reference
• Spinal mechanisms underlying A-85380-induced effects on acute thermal pain.

  2000influential reference
• Analgesic and toxic effects of ABT‐594 resemble epibatidine and nicotine in rats

  2000influential reference
• Neuronal alpha-bungarotoxin receptors are alpha7 subunit homomers.

  2000cited by this paper
• Effects of microdialyzed oxotremorine, carbachol, epibatidine, and scopolamine on intraspinal release of acetylcholine in the rat.

  2000cited by this paper
• The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model.

  2000cited by this paper
• Discovery of ABT-594 and related neuronal nicotinic acetylcholine receptor modulators as analgesic agents

  2000cited by this paper
• NK1 (substance P) receptor antagonists--why are they not analgesic in humans?

  2000cited by this paper
• The antinociceptive effects of α7 nicotinic agonists in an acute pain model

  2000cited by this paper
• Alkaloids from frog skin: the discovery of epibatidine and the potential for developing novel non-opioid analgesics.

  2000cited by this paper
• A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler

  2000cited by this paper
• Neuronal α-Bungarotoxin Receptors Are α7 Subunit Homomers

  2000cited by this paper
• Reduced nicotinic receptor-mediated antinociception following in vivo antisense knock-down in rat.

  2000cited by this paper
• The promise and pitfalls of a nicotinic cholinergic approach to pain management.

  2000cited by this paper
• Cyclooxygenase 2 inhibitors: discovery, selectivity and the future.

  1999influential reference
• Sex differences in cholinergic analgesia I: a supplemental nicotinic mechanism in normal females.

  1999cited by this paper
• The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats.

  1999cited by this paper
• Sex Differences in Supraspinal Morphine Analgesia Are Dependent on Genotype 1

  1999cited by this paper
• Emerging molecular approaches to pain therapy.

  1999cited by this paper
• Antinociceptive and pharmacological effects of metanicotine, a selective nicotinic agonist.

  1999influential reference
• Pharmacogenetic variability in neuronal nicotinic receptor-mediated antinociception.

  1999cited by this paper
• Epibatidine: high potency and broad spectrum activity on neuronal and neuromuscular nicotinic acetylcholine receptors

  1999cited by this paper
• Nicotinic cholinergic receptors: potential targets for inflammatory pain relief.

  1999cited by this paper
• Sex differences in cholinergic analgesia II: differing mechanisms in two models of allodynia.

  1999cited by this paper
• Nicotine modulates evoked GABAergic transmission in the brain.

  1999cited by this paper
• Mecamylamine blocks the development of tolerance to nicotine in rats: implications for the mechanisms of tolerance

  1999cited by this paper
• The development of cross-tolerance between morphine and nicotine in mice.

  1999cited by this paper
• The antinociception produced by microinjection of a cholinergic agonist in the ventromedial medulla is mediated by noradrenergic neurons in the A7 catecholamine cell group.

  1999cited by this paper
• Therapeutic potential of neuronal nicotinic acetylcholine receptor agonists as novel analgesics.

  1999cited by this paper
• Reduced antinociception in mice lacking neuronal nicotinic receptor subunits

  1999influential reference
• Pain inhibition, nicotine, and gender.

  1998influential reference
• Role of the Nucleus Raphe Magnus in Antinociception Produced by ABT-594: Immediate Early Gene Responses Possibly Linked to Neuronal Nicotinic Acetylcholine Receptors on Serotonergic Neurons

  1998cited by this paper
• Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice.

  1998influential reference
• Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine

  1998cited by this paper
• Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists.

  1998cited by this paper
• Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice.

  1998influential reference
• Protective effect of GTS-21, a novel nicotinic receptor agonist, on delayed neuronal death induced by ischemia in gerbils.

  1998cited by this paper
• Epibatidine and pain.

  1998cited by this paper
• ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization.

  1998cited by this paper
• Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice.

  1998cited by this paper
• Sex differences in cocaine- and nicotine-induced antinociception in the rat.

  1998cited by this paper
• Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (+/-)-epibatidine in rats.

  1998influential reference
• Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.

  1998cited by this paper
• Associative tolerance to nicotine analgesia in the rat: tail-flick and hot-plate tests.

  1998cited by this paper
• Intrathecal clonidine alleviates allodynia in neuropathic rats: interaction with spinal muscarinic and nicotinic receptors.

  1998cited by this paper
• Tobacco product regulation: context and issues.

  1998cited by this paper
• The role of neuronal nicotinic acetylcholine receptors in antinociception: effects of ABT-594.

  1998cited by this paper
• Neuronal nicotinic acetylcholine receptors in rat trigeminal ganglia.

  1998cited by this paper
• Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling.

  1998cited by this paper
• ABT-594, a novel cholinergic channel modulator, is efficacious in nerve ligation and diabetic neuropathy models of neuropathic pain.

  1998cited by this paper
• ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.

  1998cited by this paper
• Conformationally restricted analogues of nicotine and anabasine.

  1998influential reference
• Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors.

  1998influential reference
• Sex Differences in Cholinergic Analgesia in Normal Rats

  1998cited by this paper
• ABT‐089 [2‐methyl‐3‐(2‐(s)‐pyrrolidinylmethoxy) pyridine dihydrochloride]: Discriminative stimulus properties and electrophysiological actions

  1997cited by this paper
• Presynaptic nicotinic ACh receptors.

  1997cited by this paper
• ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties.

  1997cited by this paper
• Epibatidine binding sites and activity in the spinal cord.

  1997cited by this paper
• Human neuronal nicotinic receptors.

  1997cited by this paper
• The alpha-bungarotoxin-binding nicotinic acetylcholine receptor from rat brain contains only the alpha7 subunit.

  1997cited by this paper
• The molecular biology of neuronal nicotinic acetylcholine receptors.

  1997cited by this paper
• 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner.

  1997cited by this paper
• 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat α7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner

  1997cited by this paper
• The molecular biology of neuronal nicotinic acetylcholine receptors

  1997cited by this paper
• Antinociceptive profile of the new nicotinic agonist DBO‐83

  1997cited by this paper
• The α-Bungarotoxin-binding Nicotinic Acetylcholine Receptor from Rat Brain Contains Only the α7 Subunit*

  1997cited by this paper
• Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo.

  1997cited by this paper
• A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand.

  1996cited by this paper
• RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterization.

  1996cited by this paper
• Neuronal Nicotinic Receptor Expression in Sensory Neurons of the Rat Trigeminal Ganglion: Demonstration of α3β4, a Novel Subtype in the Mammalian Nervous System

  1996cited by this paper
• Nicotine potentiates morphine antinociception: a possible cholinergic mechanism.

  1996cited by this paper
• RJR-2403: a nicotinic agonist with CNS selectivity II. In vivo characterization.

  1996cited by this paper
• Evaluation of anti-nociceptive effects of neuronal nicotinic acetylcholine receptor (NAChR) ligands in the rat tail-flick assay.

  1996cited by this paper
• Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice.

  1996cited by this paper
• A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: In Vitro pharmacological properties of a novel, high affinity α4β2 nicotinic acetylcholine receptor ligand

  1996cited by this paper
• Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics.

  1995cited by this paper
• Is epibatidine really analgesic? Dissociation of the activity, temperature, and analgesic effects of (+/-)-epibatidine.

  1995cited by this paper
• Different methods of assessing nicotine-induced antinociception may engage different neural mechanisms

  1995cited by this paper
• Pharmacology of neuropathic pain.

  1995cited by this paper
• Epibatidine, a potent analgetic and nicotinic agonist.

  1994cited by this paper
• (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.

  1994influential reference
• Pharmacological effects of epibatidine optical enantiomers.

  1994cited by this paper
• Transdermal nicotine: reduction of smoking with minimal abuse liability

  1994cited by this paper
• Synthesis, optical resolution, absolute configuration, and preliminary pharmacology of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H- pyrrolo-[3,2-h]isoquinoline, a structural analog of nicotine.

  1993cited by this paper
• Multiple spinal mediators in parenteral nicotine-induced antinociception.

  1993influential reference
• Naloxone precipitates nicotine abstinence syndrome in the rat

  1993cited by this paper
• A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.

  1992cited by this paper
• Characterization of the antinociception induced by nicotine in the pedunculopontine tegmental nucleus and the nucleus raphe magnus.

  1991cited by this paper
• The TiPS lecture. The nicotinic acetylcholine receptor: an allosteric protein prototype of ligand-gated ion channels.

  1990cited by this paper
• Visceral pain.

  1948cited by this paper

• Evaluation of novel epibatidine analogs in the rat nicotine drug discrimination assay and in the rat chronic constriction injury neuropathic pain model

  2023cites this paper
• A Review of Neuroreceptors for Clinical and Experimental Neuropharmacology in Central Nervous System Disorders.

  2022cites this paper
• Acetylcholine Receptors in Mesenchymal Stem Cells

  2022cites this paper
• The Frog and the Vine

  2022cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2021cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2021cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2021cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2021cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2021cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2021cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2021cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2021cites this paper
• Recent Developments In Novel Antidepressants Targeting Ô±4ÔÂ22-Nicotinic Acetylcholine Receptors

  2021cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2020cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2020cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2020cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2020cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2020cites this paper
• Biomedical applications of snake venom: from basic science to autoimmunity and rheumatology

  2020cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2020cites this paper
• Analgesic and antipyretic natural products

  2020cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2020cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2020cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2020cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2020cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2020cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2020cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2020cites this paper
• Comparing Event Detection Methods in Single-Channel Analysis Using Simulated Data

  2019cites this paper
• Brain Gene Expression in the Context of Nicotine Rewards: A Focus on Cholinergic Genes

  2019cites this paper
• Alteration in behavior of rat after chronic exposure to acetamiprid

  2019cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2019cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2019cites this paper
• Choline attenuates inflammatory hyperalgesia activating nitric oxide/cGMP/ATP-sensitive potassium channels pathway.

  2019cites this paper
• Drug Discovery on Natural Products: From Ion Channels to nAChRs, from Nature to Libraries, from Analytics to Assays

  2019cites this paper
• Mechanistic bases for the adverse interaction of nicotine and chronic pain

  2018cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2018cites this paper
• Antinociceptive effects of novel epibatidine analogs through activation of α4β2 nicotinic receptors

  2018cites this paper
• Natural product modulators of human sensations and mood: molecular mechanisms and therapeutic potential.

  2018cites this paper
• LGANDS FOR NEURONAL NCOTINC RECEPTORS

  2017cites this paper
• Fainzilber M. et al., “A New Neurotoxin Receptor Site on Sodium Channels is Identified by a Conotoxin That Affects Sodium Channel Inactivation in Molluses and Acts as an Antagonist in Rat Brain'

  2017cites this paper
• Zoo Therapeutic uses of Snake Body Parts in Folk and Traditional Medicine

  2017cites this paper
• 2-Arylazetidines as ligands for nicotinic acetylcholine receptors

  2017cites this paper
• Plasticity in Brainstem Mechanisms of Pain Modulation by Nicotinic Acetylcholine Receptors in the Rat

  2017cites this paper
• The Effects of Varenicline on Neurocognitive Function in Non-smokers with Schizophrenia

  2016cites this paper
• Dorsal raphe nucleus acetylcholine-mediated neurotransmission modulates post-ictal antinociception: The role of muscarinic and nicotinic cholinergic receptors.

  2016cites this paper
• EFFECT OF ALCOHOLIC SALVIA OFFICINALE EXTRACT ON ANALGESIA INDUCED BY HYOSCINE IN ADULT MALE WISTAR RATS

  2015cites this paper
• Nicotinic receptors modulate the function of presynaptic AMPA receptors on glutamatergic nerve terminals in the trigeminal caudal nucleus.

  2015cites this paper
• In vivo pharmacological profile of substituted (3-pyridyl)-2-phenylisoxazolidine analogues of nicotine as novel antinociceptives

  2014influential citation
• Nicotinic Receptors as Targets for Novel Analgesics and Anti-inflammatory Drugs

  2014cites this paper
• بررسی اثر Zingiber officinale بر بی دردی ناشی از مرفین در موشهای صحرایی نر بالغ نژاد ویستار

  2014cites this paper
• Effect of Zingiber officinale on analgesia induced by Morphine in adult male Wistar rats

  2014cites this paper
• Recent Developments in Novel Antidepressants Targeting α4β2-Nicotinic Acetylcholine Receptors

  2014cites this paper
• In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model

  2013cites this paper
• The Expression and Regulation of CYP2D in a Monkey Model of Ethanol and Nicotine Exposure

  2013cites this paper
• The Antinociceptive Effects of Nicotinic Partial Agonists Varenicline and Sazetidine-A in Murine Acute and Tonic Pain Models

  2012cites this paper
• Receptor and Channel Heteromers as Pain Targets

  2012cites this paper
• Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist

  2012cites this paper
• Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors

  2012influential citation
• THE ANTINOCICEPTIVE EFFECTS OF ALPHA 7 NICOTINIC ACETYLCHOLINERECEPTOR POSITIVE ALLOSTERIC MODULATORS IN DIFFERENT ANIMAL PAINMODELS

  2012cites this paper
• Impact of Climate Change on Biodiversity

  2012cites this paper
• PATIENT SAFETY, PRACTICE MANAGEMENT

  2012cites this paper
• Diazaspirocyclic compounds as selective ligands for the α4β2 nicotinic acetylcholine receptor.

  2012cites this paper
• Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity.

  2012cites this paper
• ارزیابی اثر ضد دردی عصاری آبی الکلی میوه بادمجان در موش سوری با استفاده از آزمون Tail Flick

  2011cites this paper
• Nicotine nasal spray as an adjuvant analgesic for third molar surgery.

  2011cites this paper
• Pharmacological relationship between nicotinic and opioid systems in analgesia and corticosterone elevation.

  2011cites this paper
• Positive and Negative Effects of Alcohol and Nicotine and Their Interactions: A Mechanistic Review

  2011cites this paper
• The Evaluation of the Analgesic Effect of Hydro-Alcoholic Extract of Solanum Melongena in Syrian Mice Using Tail Flick Test

  2011cites this paper
• Pharmacokinetic Modeling and [123I]5-IA-85380 Single Photon Emission Computed Tomography Imaging in Baboons: Optimization of Dosing Regimen for ABT-089

  2011cites this paper
• Pharmacological effects of nonselective and subtype‐selective nicotinic acetylcholine receptor agonists in animal models of persistent pain

  2010cites this paper
• A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain

  2009cites this paper
• Hypothesis of snake and insect venoms against Human Immunodeficiency Virus: a review

  2009cites this paper
• The effect of formalin pretreatment on nicotine-induced antinociceptive effect: the role of mu-opioid receptor in the hippocampus.

  2008cites this paper
• Asymmetric synthesis of (+)-pyrido[3,4-b]homotropane.

  2008cites this paper
• Neuropathic pain: emerging treatments.

  2008cites this paper
• Synthesis of 2-(pyridin-3-yl)-1-azabicyclo[3.2.2]nonane, 2-(pyridin-3-yl)-1-azabicyclo[2.2.2]octane, and 2-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, a class of potent nicotinic acetylcholine receptor-ligands.

  2008cites this paper
• Smoking cessation therapy with varenicline

  2008cites this paper
• New horizons in pharmacologic treatment for rheumatic disease pain.

  2008cites this paper
• Radioligand Binding Characterization of Neuronal Nicotinic Acetylcholine Receptors

  2008cites this paper
• Analgesic Effects of Sazetidine-A, a New Nicotinic Cholinergic Drug

  2008cites this paper
• Synthesis and activity of substituted carbamates as potentiators of the alpha4beta2 nicotinic acetylcholine receptor.

  2008cites this paper
• The potential of neuronal nicotinic acetylcholine receptor agonists for treating CNS conditions

  2008cites this paper
• Tobacco/nicotine and endogenous brain opioids.

  2008cites this paper
• Morphine and ABT-594 (a nicotinic acetylcholine agonist) exert centrally mediated antinociception in the rat cyclophosphamide cystitis model of visceral pain.

  2008cites this paper
• Pharmacological MRI in awake rats predicts selective binding of alpha4beta2 nicotinic receptors.

  2008cites this paper
• Pharmaceuticals: Natural Products and Natural Product Models

  2008cites this paper
• Pharmacological MRI in awake rats predicts selective binding of α4β2 nicotinic receptors

  2008influential citation
• QSAR study of a large set of 3-pyridyl ethers as ligands of the α4β2 nicotinic acetylcholine receptor

  2007cites this paper
• Central Nicotinic Receptors: Structure, Function, Ligands, and Therapeutic Potential

  2007cites this paper
• The neurobiological bases for the pharmacotherapy of nicotine addiction.

  2007cites this paper
• QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.

  2007cites this paper
• [New antiepileptic drugs and neuropathic pain. From molecular medicine to clinical practice].

  2007cites this paper
• Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors.

  2007cites this paper
• Open radical retropubic prostatectomy 2007: the true minimally invasive surgery for localized prostate cancer?

  2007cites this paper
• Nuevos fármacos antiepilépticos y dolor neuropático. De la medicina molecular a la clínica

  2007cites this paper
• A long-form alpha-neurotoxin from cobra venom produces potent opioid-independent analgesia.

  2006cites this paper
• Snake venom components and their applications in biomedicine

  2006cites this paper
• Synthesis of conformationally restricted nicotine analogues by intramolecular [3+2] cycloaddition

  2006cites this paper
• Pharmacological MRI in awake rats reveals neural activity in area postrema and nucleus tractus solitarius: Relevance as a potential biomarker for detecting drug-induced emesis

  2006cites this paper